Q4 2024 Vicarious Surgical Inc Earnings Call Transcript
Key Points
- Vicarious Surgical Inc (RBOT) successfully completed the integration of their V1.0 system, marking a significant milestone in their development process.
- The company expanded its partnerships with top-tier hospital systems, including LSU Health New Orleans, Temple Health, and University of Illinois Health, which will aid in developing medical education and training protocols.
- Vicarious Surgical Inc (RBOT) reported a reduction in total operating expenses by 17% year-over-year, demonstrating effective expense management.
- The company achieved a favorable cash burn rate of $49 million, slightly below their original guidance, indicating strong financial discipline.
- The V1.0 system's innovative design, including decoupled actuators and advanced AI features, has garnered significant interest from leading U.S. hospital systems, highlighting its potential market impact.
- Vicarious Surgical Inc (RBOT) faced supply chain challenges, including delays in component deliverables due to issues with key suppliers, impacting their manufacturing progress.
- The timeline for treating the first clinical patients has been pushed to later in 2025, affecting the company's initial plans.
- The de novo submission for regulatory approval is now expected to be delayed until late 2026.
- The company encountered procurement challenges with certain suppliers, which led to delays in inventory buildup.
- Despite progress, the company still faces hurdles in securing institutional ethics committee approvals for international clinical sites, which could impact their clinical trial timelines.
Good afternoon. Thank you for attending the Vicarious Surgical's 2024 fourth quarter and Full Year Earnings Call. My name is Cameron, and I will be your moderator for today (Operator Instructions)
And I would now like to pass the conference over to your host, Kaitlyn Brosco, Director of IR. You may proceed.
Thank you, Cameron, and thank you all for joining. With me on today's call is Adam Sachs, Co-Founder and Chief Executive Officer; and Randy Clark, Company President. Today aftermarket closed by Vicarious Surgical released financial results for the three months and full year ended December 31, 2024. The A copy of the press release is available on the company website.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
